DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

April 30, 2006

Conditions
Nasolabial Fold Wrinkles
Interventions
DEVICE

DL6049 (injectable poly-L-lactic acid)

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00444210 - DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles | Biotech Hunter | Biotech Hunter